Ventyx Biosciences, Inc. (VTYX)
NASDAQ: VTYX · Real-Time Price · USD
13.95
-0.01 (-0.07%)
At close: Feb 3, 2026, 4:00 PM EST
13.99
+0.04 (0.29%)
After-hours: Feb 3, 2026, 7:55 PM EST
Ventyx Biosciences Market Cap
Ventyx Biosciences has a market cap or net worth of $1 billion as of February 3, 2026. Its market cap has increased by 600.75% in one year.
Market Cap
1.00B
Enterprise Value
818.30M
1-Year Change
600.75%
Ranking
Category
Stock Price
$13.95
Market Cap Chart
Since the IPO on October 21, 2021, Ventyx Biosciences's market cap has increased from $782.89M to $1.00B, an increase of 27.85%. That is a compound annual growth rate of 5.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 1.00B | 55.33% |
| Dec 31, 2025 | 644.37M | 316.11% |
| Dec 31, 2024 | 154.86M | 6.21% |
| Dec 29, 2023 | 145.80M | -92.15% |
| Dec 30, 2022 | 1.86B | 85.92% |
| Dec 31, 2021 | 998.89M | 27.59% |
| Oct 21, 2021 | 782.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aktis Oncology | 1.06B |
| Septerna | 1.05B |
| Vir Biotechnology | 1.04B |
| Iovance Biotherapeutics | 1.01B |
| Nanobiotix | 1.00B |
| ORIC Pharmaceuticals | 999.21M |
| ARS Pharmaceuticals | 987.50M |
| Zenas BioPharma | 986.09M |